Now I have a thorough understanding of the paper. Let me construct the final consolidated review.

## Summary

GRABLI proposes a self-supervised pre-training method that aligns a biomedical language model (LM) with a knowledge graph (KG) encoder via contrastive learning on entity-anchored (text, subgraph) pairs, using UMLS as the KG and PubMed abstracts as text. The method is evaluated on biomedical question answering (PubMedQA, MedQA, BioASQ) and entity linking (five corpora), with ablation studies comparing graph encoders (GAT, GraphSAGE, translation-based, linearized graphs). Results show consistent improvements over PubMedBERT and BioLinkBERT baselines, and the linearized-graph variant achieves competitive performance without an external GNN.

## Strengths

- **Consistent empirical gains across QA and EL.** GRABLI pre-training boosts PubMedBERT and BioLinkBERT on all three QA datasets (e.g., +6.2% on BioASQ, +2.1% on PubMedQA) and on zero-shot entity linking (e.g., +24.2% average Accuracy@1 for BioLinkBERT_base), as reported in Tables 1 and 2. The gains are demonstrated across multiple base models and tasks.

- **Data efficiency relative to task-specific EL models.** BioLinkBERT_base with GRABLI (using 600K UMLS concepts) matches or exceeds SapBERT (pre-trained on 4M concepts) on 2 of 5 EL corpora in zero-shot evaluation, and the paper is precise about where this comparison holds and where it does not.

- **Systematic ablation study validates architectural choices.** The paper isolates the effect of each loss component (Table 4), token aggregation method, and graph encoder configuration (Table 3), showing that both MLM and alignment losses are necessary, and that GAT-based attention outperforms mean-pooling (GraphSAGE). The comparison of graph linearization vs. external GNN (RQ3, Table 3) is a practical contribution.

## Weaknesses

### Fatal
None.

### Major

- **Missing results for relation extraction (RE).** Section 5.1 explicitly states that evaluation was performed on ChemProt, DDI, and GAR, yet no RE results appear anywhere in the provided paper — not in a table, not in text, not referenced in the results discussion. The paper does not reference an appendix that might contain these results. This is an unfulfilled empirical claim that undermines the completeness of the evaluation. The authors must either provide these results or remove the claim.

- **Downstream fine-tuning protocol is underspecified to the point of non-reproducibility.** The paper describes the GRABLI pre-training setup in detail but says essentially nothing about how models were adapted to QA and EL tasks after pre-training. For QA: Are GRABLI-pretrained models fine-tuned on each dataset, and if so, with what hyperparameters (learning rate, epochs, batch size, early stopping)? For EL: The paper mentions "supervised approach based on BioSyn" but provides no fine-tuning details. The evaluation section states comparisons are made against base models with "original weights" — it is unclear whether these base models were fine-tuned under identical conditions or evaluated zero-shot. Since base PubMedBERT without any fine-tuning cannot answer yes/no questions, the phrase "original weights" creates a structural ambiguity that makes it impossible for readers to assess whether the comparisons are fair.

- **Incomplete reporting of variance.** Table 1 reports standard deviations for PubMedQA and BioASQ but not for MedQA. Table 2 (entity linking) reports no variance at all for any metric or setting. Several reported improvements are small (1–2% on QA, a few % on some EL datasets), so variance estimates are essential to establish that the gains are reliable rather than noise. The paper states it uses 10 random seeds for some experiments but does not report confidence intervals or significance tests.

### Minor

- **Comparison to QA-GNN and GreaseLM lacks necessary context.** The paper claims GRABLI performs "on par or better than the task-specific QA-GNN and GreaseLM methods" on MedQA and BioASQ, but does not state whether these numbers are taken from original publications (with potentially different splits or fine-tuning protocols) or from re-implementations under controlled conditions. The comparison is also limited to only 2 of 3 QA datasets.

- **The paper claims alignment "may contribute to enhanced multi-hop reasoning capabilities" (introduction) but evaluates only on single-hop QA and entity linking.** No analysis of multi-step reasoning is provided, and the claim is left unsupported. This should either be substantiated (e.g., by analyzing questions requiring multi-step inference) or removed.

- **No discussion of limitations or potential negative effects.** The paper does not discuss whether GRABLI ever degrades performance relative to the base model, whether alignment is sensitive to entity linking errors from BERN2, or what types of tasks/concepts benefit most vs. least from the method.

- **The choice of up to 3 sampled neighbors for subgraphs is stated without justification or ablation.** The paper acknowledges sampling "to reduce computational cost" (following Hamilton et al., 2017) but never varies this parameter, leaving the reader to wonder whether results are sensitive to subgraph size.

- **Random sampling of concept names for initial node representations (§4.1) introduces non-determinism that is not discussed.** The paper does not state whether the same random sample is reused across training or resampled each epoch, which could affect training stability.

### Trivial
None.

## Nice-to-Haves

- Ablation varying the subgraph size (number of sampled neighbors) and number of alignment pre-training steps on a held-out validation set would give readers a sense of the method's sensitivity to cheap computational knobs.
- An analysis of BERN2's entity linking accuracy on the pre-training corpus and its potential impact on the contrastive objective would strengthen the discussion of limitations.
- Adding confidence intervals or statistical significance tests for all comparisons in Tables 1 and 2.

## Removed Points

- **Comparison to KEPLER/LUKE (missing related work).** Removed per instructions: do not mention missing related works when lacking external sources to confirm their existence.
- **Formatting/style nitpicks and concerns about typos/grammar.** Removed per instructions: these are parser artifacts, not author errors.
- **Concerns about the bioASQ chance level being 50%.** This does not weaken the contribution — relative improvement from a strong baseline is the correct metric.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Provide the RE results (or remove the claim from Section 5.1).
2. Fully specify the downstream fine-tuning protocol for all tasks: hyperparameters, number of runs, and how base model comparisons were conducted (identical protocol vs. published numbers).
3. Report standard deviations or confidence intervals for MedQA in Table 1 and for all metrics in Table 2.
4. Clarify the source of QA-GNN/GreaseLM numbers (original papers or re-implementations) and, if possible, extend the comparison to PubMedQA.
5. Either substantiate or remove the multi-hop reasoning claim from the introduction.
6. Add a limitations paragraph discussing BERN2 noise, subgraph size sensitivity, and cases where alignment may not help.

## Score and Decision

The paper presents a well-motivated method with clear empirical improvements on QA and EL. However, the missing RE results and underspecified fine-tuning protocol are substantive gaps that prevent full evaluation of the experimental claims. These are addressable in revision.

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>